3 hours Aquestive Therapeutics (NASDAQ:AQST) Receives Market Outperform Rating from JMP Securities MarketBeat
JMP Securities restated a “market outperform” rating and issued a $9.00 price objective on shares of Aquestive Therapeutics in a report on Tuesday.